Vikas Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vikas Pandey has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Vandana Soni
Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, India
7 shared publications - Tanweer Haider
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, M.P., India; Gyan Vihar School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
6 shared publications - Aditya Ganeshpurkar
Drug Discovery Laboratory, Shri Ram Institute of Technology−Pharmacy, Jabalpur, M.P., India
4 shared publications Divya Bansal
A Pharmaceutics Research Laboratory , Shri Ram Institute of Technology - Pharmacy , Jabalpur , Madhya Pradesh , India and
4 shared publicationsNazneen Dubey
B Drug Discovery Laboratory , Shri Ram Institute of Technology - Pharmacy , Jabalpur , Madhya Pradesh , India
3 shared publications- Rahul Tiwari
Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, India
3 shared publications
Latest Publications
- 22 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 21, 1-22
Pharmacists' Role in Ensuring Safe Handling and Administration of Anticancer Medications in India
Pharmacists play a significant role in oncology with respect to the safe handling and administration of anti-cancer drugs. This comprehensive review analyses pharmacists’ roles, emphasising adherence to national and international safety standards and the implementation of institutional programs for protocols, training, and certification. Pharmacists will aid in the formulation and adjustment of chemotherapy medications through Personal Protective Equipment kits and working practices. Among administration methods, intravenous chemotherapy, oral anticancer agents, and special routes, such as intrathecal, can be used. Other notable responsibilities of pharmacists' work are medication safety, occupational exposure risk, and pharmacovigilance. Pharmacists can gain practical insights through case studies and possibly help prevent and control errors by implementing systemic strategies. Pharmacists are also involved in counselling and teaching patients for treatment, managing side effects, and other policies that enhance compliance. This review provides valuable insights into interprofessional collaboration to improve patient safety and achieve optimal outcomes. Emerging technologies and innovations are having a growing impact on medication management, and pharmacists have been recognised as playing a vital role in ensuring safe adoption in oncology practice. Continuous education and professional development enable pharmacists to stay up to date on the latest advancements, providing the best possible care. This review discusses the essential contributions pharmacists make to the oncology department by improving the care, safety, and efficacy of anticancer treatment, demonstrating their commitment to excellence and adaptability in healthcare settings.
- 22 July 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Safety
- Vol. 21, 1-22
Pharmacists' Role in Ensuring Safe Handling and Administration of Anticancer Medications in India
Pharmacists play a significant role in oncology with respect to the safe handling and administration of anti-cancer drugs. This comprehensive review analyses pharmacists’ roles, emphasising adherence to national and international safety standards and the implementation of institutional programs for protocols, training, and certification. Pharmacists will aid in the formulation and adjustment of chemotherapy medications through Personal Protective Equipment kits and working practices. Among administration methods, intravenous chemotherapy, oral anticancer agents, and special routes, such as intrathecal, can be used. Other notable responsibilities of pharmacists' work are medication safety, occupational exposure risk, and pharmacovigilance. Pharmacists can gain practical insights through case studies and possibly help prevent and control errors by implementing systemic strategies. Pharmacists are also involved in counselling and teaching patients for treatment, managing side effects, and other policies that enhance compliance. This review provides valuable insights into interprofessional collaboration to improve patient safety and achieve optimal outcomes. Emerging technologies and innovations are having a growing impact on medication management, and pharmacists have been recognised as playing a vital role in ensuring safe adoption in oncology practice. Continuous education and professional development enable pharmacists to stay up to date on the latest advancements, providing the best possible care. This review discusses the essential contributions pharmacists make to the oncology department by improving the care, safety, and efficacy of anticancer treatment, demonstrating their commitment to excellence and adaptability in healthcare settings.
- 7 June 2024
- Published by Elsevier in Food Bioscience
- Vol. 60
The role of silk as natural biomaterial in food safety
- 7 June 2024
- Published by Elsevier in Food Bioscience
- Vol. 60
The role of silk as natural biomaterial in food safety
- Open Access
- 15 February 2023
- Published by IntechOpen
Advances in Natural Polymeric Nanoparticles for the Drug Delivery
Natural and biodegradable polymers have been the key area for utilizing their advantages which make them a possible option for development of various drug delivery systems. The complexity of diseases and the intrinsic drug toxicity and side effects has led to an interest for development and optimization of drug delivery systems. The advancements in nanotechnology have favored the development of novel formulations which can modulate the biopharmaceutical properties of bioactives and thus improves the pharmacological and therapeutic action. The shape, size, and charge nanoscale delivery system, such as nanoparticles (NPs) are required to be investigated and changed in order to promote and optimize the formulations. The various natural polymeric NPs (PNPs) have been found to be key tool to enhance bioavailability or specific delivery to certain site of action. In this chapter, the uses of various polymeric materials for the development of NPs as drug delivery systems for various ailments have been described. The entrapment of bioactive compounds in PNPs systems is a hopeful move toward improvement of efficacy of drug toward the treatments of various diseases.
- 15 February 2023
- Published by IntechOpen
Open AccessAdvances in Natural Polymeric Nanoparticles for the Drug Delivery
Natural and biodegradable polymers have been the key area for utilizing their advantages which make them a possible option for development of various drug delivery systems. The complexity of diseases and the intrinsic drug toxicity and side effects has led to an interest for development and optimization of drug delivery systems. The advancements in nanotechnology have favored the development of novel formulations which can modulate the biopharmaceutical properties of bioactives and thus improves the pharmacological and therapeutic action. The shape, size, and charge nanoscale delivery system, such as nanoparticles (NPs) are required to be investigated and changed in order to promote and optimize the formulations. The various natural polymeric NPs (PNPs) have been found to be key tool to enhance bioavailability or specific delivery to certain site of action. In this chapter, the uses of various polymeric materials for the development of NPs as drug delivery systems for various ailments have been described. The entrapment of bioactive compounds in PNPs systems is a hopeful move toward improvement of efficacy of drug toward the treatments of various diseases.
- 3 July 2022
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 48 (7) , 310-321
Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation
Nisin is an antibacterial peptide with anticancer properties, but the main drawback is its rapid enzymatic degradation and limited permeation across the cell membrane. This research aims to overcom...
- 3 July 2022
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 48 (7) , 310-321
Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation
Nisin is an antibacterial peptide with anticancer properties, but the main drawback is its rapid enzymatic degradation and limited permeation across the cell membrane. This research aims to overcom...
- Open Access
- 3 February 2021
- Published by University of Huddersfield Press in British Journal of Pharmacy
COVID-19: testing kits and mechanism insight COVID-19: testing kits and mechanism insight
- 3 February 2021
- Published by University of Huddersfield Press in British Journal of Pharmacy
Open AccessCOVID-19: testing kits and mechanism insight COVID-19: testing kits and mechanism insight
- Top Cited Papers
- 22 July 2020
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (5) , 1125-1151
Drug resistance in cancer: mechanisms and tackling strategies
Drug resistance developed towards conventional therapy is one of the important reasons for chemotherapy failure in cancer. The various underlying mechanism for drug resistance development in tumor includes tumor heterogeneity, some cellular levels changes, genetic factors, and others novel mechanisms which have been highlighted in the past few years. In the present scenario, researchers have to focus on these novel mechanisms and their tackling strategies. The small molecules, peptides, and nanotherapeutics have emerged to overcome the drug resistance in cancer. The drug delivery systems with targeting moiety enhance the site-specificity, receptor-mediated endocytosis, and increase the drug concentration inside the cells, thus minimizing drug resistance and improve their therapeutic efficacy. These therapeutic approaches work by modulating the different pathways responsible for drug resistance. This review focuses on the different mechanisms of drug resistance and the recent advancements in therapeutic approaches to improve the sensitivity and effectiveness of chemotherapeutics. Graphic abstract
- 22 July 2020
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (5) , 1125-1151
Top Cited PapersDrug resistance in cancer: mechanisms and tackling strategies
Drug resistance developed towards conventional therapy is one of the important reasons for chemotherapy failure in cancer. The various underlying mechanism for drug resistance development in tumor includes tumor heterogeneity, some cellular levels changes, genetic factors, and others novel mechanisms which have been highlighted in the past few years. In the present scenario, researchers have to focus on these novel mechanisms and their tackling strategies. The small molecules, peptides, and nanotherapeutics have emerged to overcome the drug resistance in cancer. The drug delivery systems with targeting moiety enhance the site-specificity, receptor-mediated endocytosis, and increase the drug concentration inside the cells, thus minimizing drug resistance and improve their therapeutic efficacy. These therapeutic approaches work by modulating the different pathways responsible for drug resistance. This review focuses on the different mechanisms of drug resistance and the recent advancements in therapeutic approaches to improve the sensitivity and effectiveness of chemotherapeutics. Graphic abstract
- 1 December 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 48, 383-392
State-of-art based approaches for anticancer drug-targeting to nucleus
- 1 December 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 48, 383-392
State-of-art based approaches for anticancer drug-targeting to nucleus
- 14 June 2018
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (1) , 49-65
RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study
- 14 June 2018
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (1) , 49-65
RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study
- 3 August 2014
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 41 (8) , 1321-1327
Targeted SLNs for management of HIV-1 associated dementia
HIV-1 associated dementia (HAD) is an evolving disease in the category of neurological disorders. Nifedipine-loaded solid lipid nanoparticles (SLNs) were developed and coated with Tween 80 to facilitate enhanced brain drug delivery for the treatment of HAD. SLNs were prepared using solvent injection method. Lipids consisted of tristearin, hydrogenated soya phosphatidylcholine (HSPC) (1.5:1 w/w). Nifedipine was model drug in this study. Tween 80 (0.5% v/v) was taken as key modulator. SLNs were characterized for particle shape, size, zeta potential, entrapment efficiency, in vitro drug release, DNA fragmentation, cytotoxicity potential and in vivo studies. The SLNs (plain and coated) were found to be in nanometric in size (∼120 nm) with more than 70% entrapment efficiency. In vitro drug release profile reflected sustained release up to 48 h. Tween 80-coated SLNs showed higher percentage of DNA fragmentation in vitro and enhanced cell viability in sulforhodamine assay (rat cortical cells) as compared to plain drug and uncoated SLNs due to facilitated uptake of SLNs and reversal of P-gp efflux by virtue of Tween 80. Biodistribution study performed on vital organs, i.e. brain, heart, liver, spleen, lungs and kidney showed increased accumulation of Tween 80-coated SLNs in the brain. Tween 80 enhanced localization of SLNs in the brain as compared to uncoated SLNs. This approach can be employed effectively to transport chemotherapeutics across the BBB for management of HIV-1 associated dementia and other ailments.
- 3 August 2014
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 41 (8) , 1321-1327
Targeted SLNs for management of HIV-1 associated dementia
HIV-1 associated dementia (HAD) is an evolving disease in the category of neurological disorders. Nifedipine-loaded solid lipid nanoparticles (SLNs) were developed and coated with Tween 80 to facilitate enhanced brain drug delivery for the treatment of HAD. SLNs were prepared using solvent injection method. Lipids consisted of tristearin, hydrogenated soya phosphatidylcholine (HSPC) (1.5:1 w/w). Nifedipine was model drug in this study. Tween 80 (0.5% v/v) was taken as key modulator. SLNs were characterized for particle shape, size, zeta potential, entrapment efficiency, in vitro drug release, DNA fragmentation, cytotoxicity potential and in vivo studies. The SLNs (plain and coated) were found to be in nanometric in size (∼120 nm) with more than 70% entrapment efficiency. In vitro drug release profile reflected sustained release up to 48 h. Tween 80-coated SLNs showed higher percentage of DNA fragmentation in vitro and enhanced cell viability in sulforhodamine assay (rat cortical cells) as compared to plain drug and uncoated SLNs due to facilitated uptake of SLNs and reversal of P-gp efflux by virtue of Tween 80. Biodistribution study performed on vital organs, i.e. brain, heart, liver, spleen, lungs and kidney showed increased accumulation of Tween 80-coated SLNs in the brain. Tween 80 enhanced localization of SLNs in the brain as compared to uncoated SLNs. This approach can be employed effectively to transport chemotherapeutics across the BBB for management of HIV-1 associated dementia and other ailments.